Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

US regulators set to approve oral antiviral against COVID-19

The FDA looks set to authorise Merck’s molnupiravir after its advisory body recommended the antiviral treatment, while Pfizer’s Paxlovid may be next

Light Chain Amyloidosis

What does the future hold for Light-chain Amyloidosis?

Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

Inizio

- PMLiVE

COVID-19 vaccines against Omicron may be fast-tracked

Regulators including the Food and Drug Administration (FDA) may treat Omicron-specific mRNA vaccines like seasonal flu vaccines, speeding up approval

- PMLiVE

Onyx Health Announces Two Top Appointments

Onyx health have made two senior appointments to their communications team

Onyx Health

- PMLiVE

Omicron prompts global action

A new variant of concern discovered in southern Africa is quickly spreading around the world, prompting government to take action

- PMLiVE

Novo Nordisk growth takes a hit with China deal

Danish diabetes specialist Novo Nordisk cuts its growth forecast for 2022 following a value-based procurement deal with the Chinese government for its insulin products

- PMLiVE

Lucid Group: Orange the World

Yesterday was International Day For The Elimination Of Violence Against Women. It marked the launch of the UNiTE to end the violence against women campaign, which runs for 16 days...

Lucid Group Communications Limited

- PMLiVE

New COVID variant causing concern

An ‘unusual constellation of mutations’ in a new variant of the virus that causes COVID-19 has scientists worried that it could impact the efficacy of vaccines

- PMLiVE

First trial of a vaccine against Alzheimer’s launches

Researchers in the US hope that the vaccine can stimulate the brain’s immune system to clear the amyloid plaques seen in Alzheimer’s

- PMLiVE

PMEA 2021: A Celebration of Excellence in Patient Engagement

After hosting a virtual ceremony in 2020, this year’s awards returned to the Royal Lancaster London hotel

From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape

Joshua Yang, Co-founder & CEO of Glyphic Biotechnologies and Co-founder of NephroSant, dives into next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and...

Impetus Digital

Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021

Toronto, ON, November 25, 2021– After a lengthy submission and voting process and amongst fierce competition, Impetus Digital has been selected as a winner of Canada’s Most Admired Corporate Cultures...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links